1. Carl G, Laux G (1990) Moclobemide in long-term treatment of depression. Psychiatr Prax 17:26–29
2. Da Prada M, Kettler R, Keller HH, Burkard WP, Muggli-Maniglio D, Haefely WE (1989) Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A1. J Pharmacol Exp Ther 248:400–414
3. Dingemanse J, Eckernäs SA, Grahnén A, Häss G, Wallnöfer A (1991) Tolerability and safety of combined fluvoxamine and moclobemide in healthy volunteers. Abstract European College of Neuropsychopharmacology Congress, October 1991
4. Feighner JP, Boyer WF, Tyler DL, Neborsky RJ (1990) Adverse consequences of fluoxetine. J Clin Psychiatry 51:222–225
5. Jauch R, Griesser E, Oesterhelt G, Arnold W, Meister W, Ziegler WH, Guentert TW (1990) Biotransformation of moclobemide in humans. Acta Psychiatr Scand Suppl 360:87–90